��������

The Leadership Team at Immune-Onc Therapeutics is responsible for setting the strategic vision and direction of the company, overseeing its clinical development programs, and fostering innovation in cancer immunotherapy. Comprised of visionary founders and experienced biotechnology leaders, the team drives collaboration among various departments, ensures alignment with the company's mission, and engages with stakeholders to effectively advance groundbreaking myeloid checkpoint inhibitors for cancer treatment.